{"id":"https://openalex.org/W2943715294","doi":"https://doi.org/10.1002/cpt.1490","title":"Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open\u2010Angle Glaucoma","display_name":"Using Healthcare Databases to Refine Understanding of Exploratory Associations Between Drugs and Progression of Open\u2010Angle Glaucoma","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W2943715294","doi":"https://doi.org/10.1002/cpt.1490","mag":"2943715294","pmid":"https://pubmed.ncbi.nlm.nih.gov/31038730"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.1490","doi":"https://doi.org/10.1002/cpt.1490","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt.1490","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041217714","display_name":"Shirley\u00a0V. Wang","orcid":"https://orcid.org/0000-0001-7761-7090","observed_orcids":["https://orcid.org/0000-0001-7761-7090"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shirley V. Wang","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100369020","display_name":"Ning Li","orcid":"https://orcid.org/0000-0002-3549-8318","observed_orcids":["https://orcid.org/0000-0002-3549-8318"]},"institutions":[{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ning Li","raw_affiliation_strings":["Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063328522","display_name":"Dennis S. Rice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Dennis S. Rice","raw_affiliation_strings":["Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071232167","display_name":"Cynthia L. Grosskreutz","orcid":"https://orcid.org/0000-0001-8731-0463","observed_orcids":["https://orcid.org/0000-0001-8731-0463"]},"institutions":[{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Cynthia L. Grosskreutz","raw_affiliation_strings":["Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108281262","display_name":"Thaddeus P. Dryja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1287163989","display_name":"Massachusetts Eye and Ear Infirmary","ror":"https://ror.org/04g3dn724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1287163989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thaddeus P. Dryja","raw_affiliation_strings":["Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1287163989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091860060","display_name":"Ganesh Prasanna","orcid":"https://orcid.org/0000-0001-6420-270X","observed_orcids":["https://orcid.org/0000-0001-6420-270X"]},"institutions":[{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ganesh Prasanna","raw_affiliation_strings":["Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024696797","display_name":"Joyce Lii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joyce Lii","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059157113","display_name":"Joshua J. Gagne","orcid":"https://orcid.org/0000-0001-5428-9733","observed_orcids":["https://orcid.org/0000-0001-5428-9733"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua J. Gagne","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5041217714"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":2.2075,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.85337898,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"106","issue":"4","first_page":"874","last_page":"883"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/open-angle-glaucoma","display_name":"open-angle glaucoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/glaucoma-progression","display_name":"glaucoma progression","score":0.878000020980835},{"id":"https://openalex.org/keywords/glaucoma-filtering-surgery","display_name":"glaucoma filtration surgery","score":0.9819999933242798},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9490000009536743},{"id":"https://openalex.org/keywords/thiazide-diuretics","display_name":"thiazide diuretics","score":0.8289999961853027},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8920000195503235},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.9739999771118164},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9259999990463257},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.996999979019165},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9200000166893005},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.39500001072883606},{"id":"https://openalex.org/keywords/pharmacoepidemiology","display_name":"pharmacoepidemiology","score":0.675000011920929},{"id":"https://openalex.org/keywords/inverse-probability-of-treatment-weighting","display_name":"inverse probability of treatment weighting","score":0.7960000038146973},{"id":"https://openalex.org/keywords/intention-to-treat-analysis","display_name":"intention-to-treat analysis","score":0.6639999747276306},{"id":"https://openalex.org/keywords/as-treated-analysis","display_name":"as-treated analysis","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6972990036010742},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.5598418712615967},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47554776072502136},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.4660792052745819},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36799129843711853},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.18131786584854126}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005902","descriptor_name":"Glaucoma, Open-Angle","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015986","descriptor_name":"Confounding Factors, Epidemiologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cpt.1490","doi":"https://doi.org/10.1002/cpt.1490","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cpt.1490","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:31038730","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31038730","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308347","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W761034307","https://openalex.org/W1481813571","https://openalex.org/W1496419775","https://openalex.org/W1768004330","https://openalex.org/W1981535076","https://openalex.org/W1982964713","https://openalex.org/W1988307274","https://openalex.org/W1994870603","https://openalex.org/W1995393500","https://openalex.org/W2012887262","https://openalex.org/W2014415089","https://openalex.org/W2041643020","https://openalex.org/W2045194896","https://openalex.org/W2045972479","https://openalex.org/W2046959770","https://openalex.org/W2057266151","https://openalex.org/W2061326496","https://openalex.org/W2074630553","https://openalex.org/W2082911769","https://openalex.org/W2100083659","https://openalex.org/W2123215356","https://openalex.org/W2140594570","https://openalex.org/W2142891498","https://openalex.org/W2148890166","https://openalex.org/W2160605010","https://openalex.org/W2164595809","https://openalex.org/W2169961704","https://openalex.org/W2320048420","https://openalex.org/W2342435646","https://openalex.org/W2401668961","https://openalex.org/W2409509767","https://openalex.org/W2576460638","https://openalex.org/W2787744983","https://openalex.org/W7074114429"],"related_works":["https://openalex.org/W6987791250","https://openalex.org/W2074630553","https://openalex.org/W2989224661","https://openalex.org/W7162035114","https://openalex.org/W2787744983","https://openalex.org/W4387099105","https://openalex.org/W2979889407","https://openalex.org/W2075299947","https://openalex.org/W2040795177","https://openalex.org/W4408393056"],"abstract_inverted_index":{"We":[0,36,50],"sought":[1],"to":[2,28,42,79],"refine":[3],"understanding":[4],"about":[5],"associations":[6],"identified":[7],"in":[8,46,83,128,134],"prior":[9],"studies":[10],"between":[11,143],"angiotensin-II":[12],"receptor":[13],"blockers,":[14],"metformin,":[15],"selective":[16,120],"serotonin":[17,121],"reuptake":[18,122],"inhibitors,":[19],"fibric-acid":[20],"derivatives,":[21],"or":[22],"calcium":[23,86,144],"channel":[24,87,145],"blockers":[25,88,146],"and":[26,58,63,102,147],"progression":[27,78,118,149],"glaucoma":[29,34,80],"filtration":[30,81],"surgery":[31,82],"for":[32,52,75,119,140,152],"open-angle":[33],"(OAG).":[35],"used":[37],"new-initiator,":[38],"active-comparator":[39],"cohort":[40],"designs":[41],"investigate":[43],"these":[44],"drugs":[45],"two":[47],"data":[48,69],"sources.":[49],"adjusted":[51],"confounders":[53],"using":[54,61],"stabilized":[55],"inverse-probability-of-treatment":[56],"weights":[57],"evaluated":[59],"results":[60],"\"intention-to-treat\"":[62],"\"as-treated\"":[64],"follow-up":[65,104],"approaches.":[66],"In":[67],"both":[68],"sources,":[70],"Kaplan-Meier":[71],"curves":[72],"showed":[73],"trends":[74],"more":[76],"rapid":[77],"patients":[84],"taking":[85],"compared":[89,124],"with":[90,92,125],"thiazides":[91],"as-treated":[93],"(MarketScan":[94,105],"P":[95,99,106,110],"=":[96,100,111],"0.15;":[97],"Medicare":[98,109],"0.03)":[101],"intention-to-treat":[103],"<":[107],"0.01;":[108],"0.10).":[112],"There":[113],"was":[114,131],"suggestion":[115],"of":[116],"delayed":[117],"inhibitor":[123],"tricyclic":[126],"antidepressants":[127],"Medicare,":[129],"which":[130],"not":[132,151],"observed":[133],"MarketScan.":[135],"Our":[136],"study":[137],"provided":[138],"support":[139],"a":[141],"relationship":[142],"OAG":[148],"but":[150],"other":[153],"investigated":[154],"drugs.":[155]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2019-05-09T00:00:00"}